Skip to main content
Journal cover image

Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.

Publication ,  Journal Article
Zeitler, EP; Li, Y; Silverstein, AP; Russo, AM; Poole, JE; Daniels, MR; Al-Khalidi, HR; Lee, KL; Bahnson, TD; Anstrom, KJ; Packer, DL ...
Published in: J Am Heart Assoc
February 7, 2023

Background Women with atrial fibrillation (AF) demonstrate more AF-related symptoms and worse quality of life (QOL). Whether increased use of ablation in women reduces sex-related QOL differences is unknown. Sex-related outcomes for ablation versus drug therapy was a prespecified analysis in the CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial. Methods and Results Symptoms were assessed periodically over 60 months with the Mayo AF-Specific Symptom Inventory (MAFSI) frequency score, and QOL was assessed with the Atrial Fibrillation Effect on Quality of Life (AFEQT) summary and component scores. Women had lower baseline QOL scores than men (mean AFEQT scores 55.9 and 65.6, respectively). Ablation patients improved more than drug therapy patients with similar treatment effect by sex: AFEQT 12-month mean adjusted treatment difference in women 6.1 points (95% CI, 3.5-8.6) and men 4.9 points (95% CI, 3.0-6.9). Participants with baseline AFEQT summary scores <70 had greater QOL improvement, with a mean treatment difference at 12 months of 7.6 points for women (95% CI, 4.3-10.9) and 6.4 points for men (95% CI, 3.3-9.4). The mean adjusted difference in MAFSI frequency score between women randomized to ablation versus drug therapy at 12 months was -2.5 (95% CI, -3.4 to -1.6); for men, the difference was -1.3 (95% CI, -2.0 to -0.6). Conclusions Compared with drug therapy for AF, ablation resulted in more QOL improvement in both sexes, primarily driven by improvements in those with lower baseline QOL. Ablation did not eliminate the AF-related QOL gap between women and men. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT00911508.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

February 7, 2023

Volume

12

Issue

3

Start / End Page

e027871

Location

England

Related Subject Headings

  • Treatment Outcome
  • Surveys and Questionnaires
  • Quality of Life
  • Male
  • Humans
  • Female
  • Catheter Ablation
  • Atrial Fibrillation
  • Anti-Arrhythmia Agents
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zeitler, E. P., Li, Y., Silverstein, A. P., Russo, A. M., Poole, J. E., Daniels, M. R., … CABANA Investigators, . (2023). Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial. J Am Heart Assoc, 12(3), e027871. https://doi.org/10.1161/JAHA.122.027871
Zeitler, Emily P., Yanhong Li, Adam P. Silverstein, Andrea M. Russo, Jeanne E. Poole, Melanie R. Daniels, Hussein R. Al-Khalidi, et al. “Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.J Am Heart Assoc 12, no. 3 (February 7, 2023): e027871. https://doi.org/10.1161/JAHA.122.027871.
Zeitler EP, Li Y, Silverstein AP, Russo AM, Poole JE, Daniels MR, et al. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial. J Am Heart Assoc. 2023 Feb 7;12(3):e027871.
Zeitler, Emily P., et al. “Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.J Am Heart Assoc, vol. 12, no. 3, Feb. 2023, p. e027871. Pubmed, doi:10.1161/JAHA.122.027871.
Zeitler EP, Li Y, Silverstein AP, Russo AM, Poole JE, Daniels MR, Al-Khalidi HR, Lee KL, Bahnson TD, Anstrom KJ, Packer DL, Mark DB, CABANA Investigators. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial. J Am Heart Assoc. 2023 Feb 7;12(3):e027871.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

February 7, 2023

Volume

12

Issue

3

Start / End Page

e027871

Location

England

Related Subject Headings

  • Treatment Outcome
  • Surveys and Questionnaires
  • Quality of Life
  • Male
  • Humans
  • Female
  • Catheter Ablation
  • Atrial Fibrillation
  • Anti-Arrhythmia Agents
  • 3201 Cardiovascular medicine and haematology